Fred E. Cohen - Jul 26, 2023 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Jul 26, 2023
Transactions value $
$661,494
Form type
4
Date filed
7/28/2023, 06:06 PM
Previous filing
Jun 21, 2023
Next filing
Sep 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Award $661K +69.3K $9.54 69.3K Jul 26, 2023 by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the reporting person's proportionate interest in shares acquired by entities affiliated with Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer